news – Page 5292 – pharmaceutical daily

May 31, 2019 Off

Adaptive Biotechnologies appoints Kevin Conroy and Michelle Griffin to board of directors

Adaptive Biotechnologies today announced Kevin Conroy, chairman and CEO
of Exact Sciences Corporation, and Michelle Griffin, director at Acer
Therapeutics, Inc. and HTG Molecular Diagnostics, Inc., have been
elected to the board of directors. Board member Arnold J. Levine, PhD,
has transitioned to Adaptive’s scientific advisory board.

May 30, 2019 Off

Lantheus Announces Strategic Collaboration with NanoMab to Provide a Novel Biomarker for Clinical Development and Management of Immuno-Oncology Therapies

By BusinessWire

Lantheus expands into immuno-oncology and pharmaceutical services business through the license of NanoMab’s NM-01, an anti-PD-L1 imaging biomarker, designed to…

May 30, 2019 Off

Schrödinger to Present at the Jefferies 2019 Global Healthcare Conference

By BusinessWire

Schrödinger
today announced that Ramy Farid, Ph.D., chief executive officer, will
present at the Jefferies 2019 Global Healthcare Conference on Thursday,
June 6, 2019 at 11:00 a.m. ET in New York, NY.

May 30, 2019 Off

IQVIA Real World Capabilities and Expertise Support Path to Label Expansion

By BusinessWire

Previously announced FDA approval of IBRANCE® (palbociclib) for the treatment of men with metastatic breast cancer based in part on…

May 30, 2019 Off

4D Molecular Therapeutics Announces Presentation of Preclinical Data at the 6th International Update on Fabry Disease and Provides Clinical Update

By BusinessWire

– Novel vector, 4D-C102, demonstrates superior performance compared to commonly used AAV1, AAV8, and AAV9 – – Fabry product candidate,…

May 30, 2019 Off

Immunomic Therapeutics to Present at China Focus @BIO Philadelphia

By BusinessWire

ROCKVILLE, Md.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/allergies?src=hash" target="_blank"gt;#allergieslt;/agt;–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will…

May 30, 2019 Off

Bioasis Appoints Mario Saltarelli as Non-Executive Director of the Board of Directors

By BusinessWire

GUILFORD, Conn.–(BUSINESS WIRE)–BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), ), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the…

May 30, 2019 Off

ProtoKinetix First in Series of Town Hall Shareholder Meetings

By BusinessWire

MARIETTA, Ohio–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AAGP?src=hash" target="_blank"gt;#AAGPlt;/agt;–ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB:PKTX) today announces that it will hold the first…

May 30, 2019 Off

Sarah Cannon to Present Latest Cancer Research Insights at 2019 American Society of Clinical Oncology’s Annual Meeting

By BusinessWire

NASHVILLE, Tenn.–(BUSINESS WIRE)–Today, Sarah Cannon announced that it will present its latest cancer research insights through more than 100 abstracts…

May 30, 2019 Off

Canntab Signs Term Sheet with Heritage for Processing Hemp for Sale of CBD Filled Gelcaps

By BusinessWire

– Canntab Makes Progress Towards Becoming Revenue-Generating in 2019 – TORONTO–(BUSINESS WIRE)–Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the “Company” or “Canntab“), the leading…